ADCT

ADC Therapeutics SA

NYSE · Healthcare

$1.28

-5.19% today

last filing 2026-06-30Pro sees filings in ~15 min

Price

hover · 4 moves explained

No open-market activity

Analyst consensus

Strong Buy

$8.20target+540.6%vs $1.28 today

$6.00 low today target$10.00 high

5 analysts · ~12-month consensus · as of Jun 3. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 2 of last 4

Earnings per share · actual vs forecast

Q2 '25-4.9%

−$0.50

exp −$0.48

Q3 '25+17.4%

−$0.30

exp −$0.36

Q4 '25+85.1%

−$0.04

exp −$0.27

Q1 '26-4.1%

−$0.21

exp −$0.20

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Grant	2026-07-02	Zaki Mohamed	Chief Medical Officer	—Direct	213,900	—	—
Grant	2026-07-02	GRAHAM PETER J	Chief Legal Officer	—Direct	221,100	—	—
Grant	2026-07-02	Carmona Jose	Chief Financial Officer	—Direct	203,700	—	—
Tax	2026-06-03	Monges Viviane	Director	—Direct	2,596	$3.08	$8.0K
Grant	2026-06-03	Monges Viviane	Director	—Direct	45,000	—	—

Grant

Zaki Mohamed

Chief Medical Officer · 2026-07-02

—

213,900 shares

Grant

GRAHAM PETER J

Chief Legal Officer · 2026-07-02

—

221,100 shares

Grant

Carmona Jose

Chief Financial Officer · 2026-07-02

—

203,700 shares

Tax

Monges Viviane

Director · 2026-06-03

$8.0K

2,596 @ $3.08

Grant

Monges Viviane

Director · 2026-06-03

—

45,000 shares

34 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →